Forty-six enriched pathways were found, 22 of which (or 47.8%) were related to NAFLD (Supplementary Table 5), like for example “adipogenesis”, “sirtuin signalling”, “mTOR signalling”, “PI3K/Akt signalling”, “B Cell receptor signalling”, and “hepatic fibrosis”13,14,26,27. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.